[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367808-105":59,"doc-detail-367808-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","disease-specific-n-glycopeptides-in-serum-of-patients-with-oral-squamous-cell-carcinoma-research-findings-and-biomarker-potential","Disease-specific N-glycopeptides in serum of patients with oral squamous cell carcinoma - research findings and biomarker potential","","Disease-specific serum N-glycopeptides were investigated for patients with oral squamous cell carcinoma (OSCC) using label-free mass spectrometry-based proteomics and N-glycopeptidomics. Quantitative differences in serum protein expression between OSCC and healthy controls were modest (≤2-fold), while distinct glycoforms showed pronounced changes (7–33-fold). Twenty-five N-glycopeptides from seven proteins were identified, and OSCC-associated glycosylation patterns differed from those reported for oropharyngeal cancer, indicating disease specificity. Results support N-glycosylation alterations as potential OSCC-specific blood biomarkers for earlier detection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/disease-specific-n-glycopeptides-in-serum-of-patients-with-oral-squamous-cell-carcinoma-research-findings-and-biomarker-potential/367808/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/disease-specific-n-glycopeptides-in-serum-of-patients-with-oral-squamous-cell-carcinoma-research-findings-and-biomarker-potential/367808.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are blood-based biomarkers important for oral cancer patients?","Question",{"text":112,"@type":113},"OSCC is often diagnosed at an advanced stage, which worsens prognosis. Blood-based biomarkers could enable earlier detection and improve outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were serum N-glycopeptides and proteins analyzed in this study?",{"text":117,"@type":113},"Serum samples underwent desalting and albumin depletion, proteins were digested with trypsin, and peptides/N-glycopeptides were enriched by size exclusion chromatography. Label-free mass spectrometry was used for quantification and identification.",{"name":119,"@type":110,"acceptedAnswer":120},"What magnitude of changes in glycoforms was observed between OSCC patients and healthy controls?",{"text":121,"@type":113},"Protein expression differences were modest (≤2-fold), whereas specific glycoforms showed larger fold changes ranging from 7 to 33.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367808,1790211929,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDisease-specific N-glycopeptidesin serum of patients with oralsquamous cell carcinoma  \nTiialottaTohmola1,2􀀍, Sakari Joenväärä1,2, Amy Dickinson3,4, Antti Mäkitie3,4 & Suvi Silén3,4  \nThe incidence of oropharyngeal cancers is increasing due to human papillomavirus (HPV); however, this phenomenon does not explain the rising incidence of oral cancers, for which the reason remains unknown. These cancers are typically diagnosed at an advanced stage, which adversely affects the prognosis. Improved methods for early detection, such as blood-based biomarkers, could significantly improve patient outcomes. We investigated quantitative and qualitative differences in serum protein N-glycosylation between patients with oral squamous cell carcinoma (OSCC) and healthy controls using label-free mass spectrometry-based proteomics and N-glycopeptidomics. Twentyfive N-glycopeptides from seven different proteins were identified, all glycoforms associated with abundant serum proteins. While protein expression differences between OSCC and controls were modest (≤ 2-fold), certain glycoforms showed pronounced changes, with fold differences ranging from 7 to 33, highlighting their role as potential biomarkers. Importantly, the glycosylation patterns observed in OSCC were distinct from those previously reported in oropharyngeal cancer, suggesting a level of disease specificity. These observations support the future potential of N-glycosylation changes to serve as cancer-specific biomarkers.  \nKeywords OSCC, Oral cancer, Tongue cancer, Mass spectrometry, Proteomics, N-glycoproteomics  \nAbbreviations  \nA1AG1 Alpha-1-acid glycoprotein 1 AFP Alpha-fetoprotein  \nDDA Data-dependent acquisition DIA Data-independent acquisition ESI Electrospray ionization  \nHCC Hepatocellular carcinoma  \nHPT Haptoglobin  \nHPV Human papilloma virus  \nIGHA1 Immunoglobulin heavy constant alpha −1  \nIGHG1/2 Immunoglobulin heavy constant gamma −1, −2 IGHM Immunoglobulin heavy constant mu  \nLC-MS Liquid chromatography mass spectrometry MS Mass spectrometry  \nOPSCC Oropharyngeal squamous cell carcinoma OSCC Oral squamous cell carcinoma  \nPCA Principal component analysis PSA Prostate-specific antigen  \nPTM Post-translational modifications  \nSEC Size exclusion chromatography  \nTRFE Serotransferrin  \nUDMSE Ultra-definition mass spectrometry  \nUPLC Ultra-performance liquid chromatography  \n1Transplantation Laboratory, Haartman Institute and Helsinki University Hospital, University of Helsinki, PL 21 (Haartmaninkatu 3), Helsinki 00014, Finland. 2HUSLAB, Helsinki University Hospital, Helsinki, Finland. 3Department of Otorhinolaryngology—Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. 4Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.  \n􀀍 email: [tiialotta.tohmola@helsinki.fi](tiialotta.tohmola@helsinki.fi)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nCancers ofthe oral cavity are almost exclusively oral squamous cell carcinomas (OSCCs)1. Of all head and necksquamous cell carcinomas, OSCC – together with oropharyngeal squamous cell carcinoma (OPSCC)– is the most common cancer type2. In 2022, oral cancer (together with cancer of the lip) was the 16th most common cancer worldwide, with over 389,485 new cases and more than 188,230 deaths3. Moreover, oral cancer is nearly three times more common in males than females worldwide, and has a mortality rate of 48%3. Alcohol and smoking tobacco are considered risk factors for OSCC2.  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \n◂Fig. 1. Study workflow. This figure outlines the overall study workflow. (A) Serum samples were collected from patients with OSCC (yellow) and healthy controls (blue), followed by desalting and albumin depletion of the samples. (B) Next, proteins were digested enzymatically using seq","cbCaiihtuT5mZsBO","https://ap.wps.com/l/cbCaiihtuT5mZsBO","pdf",1832059,12,"English","# Study rationale and clinical need\n## Research approach and analytical workflow\n# Key results: glycoform changes and specificity\n## Candidate biomarker implications","[{\"question\":\"Why are blood-based biomarkers important for oral cancer patients?\",\"answer\":\"OSCC is often diagnosed at an advanced stage, which worsens prognosis. Blood-based biomarkers could enable earlier detection and improve outcomes.\"},{\"question\":\"How were serum N-glycopeptides and proteins analyzed in this study?\",\"answer\":\"Serum samples underwent desalting and albumin depletion, proteins were digested with trypsin, and peptides/N-glycopeptides were enriched by size exclusion chromatography. Label-free mass spectrometry was used for quantification and identification.\"},{\"question\":\"What magnitude of changes in glycoforms was observed between OSCC patients and healthy controls?\",\"answer\":\"Protein expression differences were modest (≤2-fold), whereas specific glycoforms showed larger fold changes ranging from 7 to 33.\"}]","Disease-specific N-glycopeptides in serum of patients with oral squamous cell carcinoma - research findings and biomarker potential | PDF",1790172776,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01df1fc54e5c9b82ff51a655611a595a.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca94d5c51b9022fdc1bc763574008db5.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07d13ad197e18b63f5d7ad7ec9d9c333.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/597318de4ad228dd56a1066703ea9e07.webp",980,1287]